Company: EDSA
Filing Date: 2025-05-28
Form Type: S-8
Source: 0001171843-25-003499
Chunk: 3

Company: Edesa Biotech, Inc.
Filing Date: 2025-05-28
Form: S-8
Chunk 3
---
 to
constitute a part of this Registration Statement. The Registrant’s file number with the Commission is No. 001-37619.

Item 8. Exhibits.

The following exhibits are filed
as part of this Registration Statement:

| Exhibit 
 Number  |                     |                                                                                |      | Incorporated by Reference |             |           |         |      |             |            |     | Filed    
 Herewith |
|         | Exhibit Description |                                                                                | Form |                           | File Number |           | Exhibit |      | Filing Date |            |     |          |
| 5.1     |                     | Opinion of Fasken Martineau Dumoulin LLP                                       |      |                           |             |           |         |      |             |            |     | X        |
| 10.1    |                     | Edesa Biotech, Inc. 2019 Equity Incentive Compensation Plan                    |      | 8-K                       |             | 001-37619 |         | 10.1 |             | 10/25/2019 |     |          |
| 10.2    |                     | Amendment No. 1 to Edesa Biotech, Inc. 2019 Equity Incentive Compensation Plan |      | 8-K                       |             | 001-37619 |         | 10.1 |             | 4/23/2021  |     |          |
| 10.3    |                     | Amendment No. 2 to Edesa Biotech, Inc. 2019 Equity Incentive Compensation Plan |      | 8-K                       |             | 001-37619 |         | 10.1 |             | 5/24/2023  |     |          |
| 10.4    |                     | Amendment No. 3 to Edesa Biotech, Inc. 2019 Equity Incentive Compensation Plan |      | 8-K                       |             | 001-37619 |         | 10.1 |             | 5/30/2024  |     |          |
| 10.5    |                     | Amendment No. 4 to Edesa Biotech, Inc. 2019 Equity Incentive Compensation Plan |      | 8-K                       |             | 001-37619 |         | 10.1 |             | 5/28/2025  |     |          |
| 23.1    |                     | Consent of Fask